Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actair (300 IR SLIT) in Children and Adolescents With House Dust Mite Allergic Rhinitis
NCT01199133Phase 3Terminated
- Sponsor
- Stallergenes Greer
- Start
- Oct 2009
- Primary completion
- Jan 2011
- Modality
- Allergy Immunotherapy
01
Overview
A Phase 3 trial of House dust mite allergen extract in allergic rhinitis (AR), sponsored by Stallergenes Greer. Started Oct 2009; status: terminated.
02
Drugs
House dust mite allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01199133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01199133.